Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00313963Phase 3Completed
Phase 3, randomised, double-blind trial of magnesium sulfate in sickle cell anemia (SCA), sponsored by SickKids. Primary endpoint: Length of stay. Started Apr 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00313963.